表紙
市場調査レポート

GliaCure Inc.の製品パイプライン分析

GliaCure Inc. - Product Pipeline Review - 2015

発行 Global Markets Direct 商品コード 321964
出版日 ページ情報 英文 22 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.32円で換算しております。
Back to Top
GliaCure Inc.の製品パイプライン分析 GliaCure Inc. - Product Pipeline Review - 2015
出版日: 2015年12月16日 ページ情報: 英文 22 Pages
概要

GliaCure Inc.は米国に本社を置く製薬企業で、グリア由来の神経疾患および神経精神障害の治療薬を開発しています。同社は、グリアを利用し、脳機能の健康/障害を制御するための創薬を行っています。

当レポートでは、GliaCure Inc.における治療薬開発パイプラインの現況と各開発段階の比較分析、薬剤標的、作用機序、投与経路、分子タイプ別の治療薬の評価、最新の企業ニュースや発表、後期段階および中止されたプロジェクトに関する情報などを提供しています。

目次

GliaCure Inc.の基本情報

  • GliaCure Inc.の概要
  • 主要情報
  • 企業情報

GliaCure Inc.:R&Dの概要

  • 主な治療範囲

GliaCure Inc.:パイプラインのレビュー

  • 開発段階別のパイプライン製品
  • 単剤製品

GliaCure Inc.:パイプライン製品の概況

  • 臨床段階にあるパイプライン製品
    • 第1相の製品/併用療法モダリティ
  • 初期段階にあるパイプライン製品
    • 前臨床段階の製品/併用療法モダリティ
    • 創薬中の製品/併用療法モダリティ

GliaCure Inc.:薬剤プロファイル

  • GC-021109
  • Drug for Depression
  • Drug for CNS Disorders

GliaCure Inc.:パイプライン分析

  • 投与経路別

GliaCure Inc.:最新のパイプライン情報

GliaCure Inc.:本社と子会社の所在地

  • 本社

付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GMDHC07884CDB

Summary

Global Markets Direct's, 'GliaCure Inc. - Product Pipeline Review - 2015', provides an overview of the GliaCure Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of GliaCure Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of GliaCure Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of GliaCure Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the GliaCure Inc.'s pipeline products

Reasons to buy

  • Evaluate GliaCure Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of GliaCure Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the GliaCure Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of GliaCure Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of GliaCure Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of GliaCure Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • GliaCure Inc. Snapshot
    • GliaCure Inc. Overview
    • Key Information
    • Key Facts
  • GliaCure Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • GliaCure Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • GliaCure Inc. - Pipeline Products Glance
    • GliaCure Inc. - Clinical Stage Pipeline Products
      • Phase I Products/Combination Treatment Modalities
    • GliaCure Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • GliaCure Inc. - Drug Profiles
    • GC-021109
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Drug for Depression
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Drug for CNS Disorders
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • GliaCure Inc. - Pipeline Analysis
    • GliaCure Inc. - Pipeline Products by Target
    • GliaCure Inc. - Pipeline Products by Route of Administration
    • GliaCure Inc. - Pipeline Products by Molecule Type
    • GliaCure Inc. - Pipeline Products by Mechanism of Action
  • GliaCure Inc. - Recent Pipeline Updates
  • GliaCure Inc. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • GliaCure Inc., Key Information
  • GliaCure Inc., Key Facts
  • GliaCure Inc. - Pipeline by Indication, 2015
  • GliaCure Inc. - Pipeline by Stage of Development, 2015
  • GliaCure Inc. - Monotherapy Products in Pipeline, 2015
  • GliaCure Inc. - Phase I, 2015
  • GliaCure Inc. - Preclinical, 2015
  • GliaCure Inc. - Discovery, 2015
  • GliaCure Inc. - Pipeline by Target, 2015
  • GliaCure Inc. - Pipeline by Route of Administration, 2015
  • GliaCure Inc. - Pipeline by Molecule Type, 2015
  • GliaCure Inc. - Pipeline Products by Mechanism of Action, 2015
  • GliaCure Inc. - Recent Pipeline Updates, 2015

List of Figures

  • GliaCure Inc. - Pipeline by Top 10 Indication, 2015
  • GliaCure Inc. - Pipeline by Stage of Development, 2015
  • GliaCure Inc. - Monotherapy Products in Pipeline, 2015
  • GliaCure Inc. - Pipeline by Top 10 Target, 2015
  • GliaCure Inc. - Pipeline by Top 10 Route of Administration, 2015
  • GliaCure Inc. - Pipeline by Top 10 Molecule Type, 2015
  • GliaCure Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top